跳至主要内容
临床试验/IRCT20210822052258N1
IRCT20210822052258N1招募中3 期

Evaluation of the efficacy of topical Gabapentin for the treatment of pruritus in patients with Epidermolysis bullosa, Faghihi hospital, 2021

Shiraz University of Medical Sciences0 个研究点目标入组 19 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
19

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
6 years 至 no limit(—)
性别
All

入选标准

  • Age equal or more than 6 years;
  • Histologically confirmed any three major forms of epidermolysis bullosa (EB simplex (EBS), junctional EB (JEB), and dystrophic EB (DEB))
  • complain of persistent pruritic lesions unresponsive to the standard treatment

排除标准

  • Use of oral gabapentin
  • Pregnancy or lactation
  • Concomitant kidney, liver, blood, thyroid, and psychiatric diseases or any other systemic disease that may cause pruritus

研究者

相似试验